Intervention not reported
Prebiotics/Probiotics/Synbiotics(15 trials; 763 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Prebiotics/Probiotics/Synbiotics(6 trials; 318 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Prebiotics/Probiotics/Synbiotics(6 trials; 296 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Prebiotics/Probiotics/Synbiotics(5 trials; 289 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Probiotics (2 RCTs; 105 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes probiotics (2 RCTs; 105 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Probiotics (3 RCTs; 108 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes probiotics (3 RCTs; 108 participants) (very low certainty).
1 finding from 1 review
Selective bowel decontamination versus prebiotics with probiotics · people undergoing liver transplantation
2 findings from 1 review
Prebiotics with probiotics versus prebiotics · people undergoing liver transplantation
2 findings from 1 review
Mortality ‐ Prebiotics and probiotics versus none · patients undergoing liver resections
1 finding from 1 review
Mortality ‐ Pre‐operative and post‐operative prebiotics and probiotics versus post‐operative prebiotics and probiotics · patients undergoing liver resections
1 finding from 1 review
Clinical relapse · people in remission or with mildly activeulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · people in remission or with mildly activeulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · people in remission or with mildly activeulcerative colitis
1 finding from 1 review
Total adverse events · people in remission or with mildly activeulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people in remission or with mildly activeulcerative colitis
It is very uncertain whether prebiotics changes withdrawals due to adverse events (4 weeks) compared with probiotics (very low certainty).
1 finding from 1 review
Failure to induce clinical remission at end of study · people with active UC
It is very uncertain whether antibiotics changes failure to induce clinical remission at end of study compared with probiotics (very low certainty).
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
1 finding from 1 review
Treatment success as defined by the authors · children (4 to 18 years) with functional abdominal pain disorders
Probiotic may leads to higher treatment success (at study end, as reported by study authors) compared with placebo (low certainty).
1 finding from 1 review